Fortis Malar Hospitals (Small Cap) Share Target 2026, 2027 To 2035
|
Fortis Malar Hospitals Limited |
|||
|
Price: ₹53.15 (1.47%) | ||
| 52 Week Low: ₹40.75 52 Week High: ₹77.00 |
|||
| Market Capital: 108.06 Crore (Small-cap) | |||
| -> | |||
Share Price HistoryFORTISMLR FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Fortis Malar Hospitals Share Price Target For 2026
- 1.1.1: Fortis Malar Hospitals Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Fortis Malar Hospitals Share Price Target For 2027
- 1.2.1: Fortis Malar Hospitals Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Fortis Malar Hospitals Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Fortis Malar Hospitals Financial Performance
- 3.0.1: Is Fortis Malar Hospitals A Good Buy For Long Term?
Fortis Malar Hospitals, a Small Cap company has delivered 1.1% returns in 3-year with 85.1% profit margin.
To predict the Fortis Malar Hospitals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Fortis Malar Hospitals Share Price Target For 2026
The line chart displays the monthly closing prices of Fortis Malar Hospitals with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fortis Malar Hospitals shares in 2026, see the table below.
Fortis Malar Hospitals Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 55.61 (+4.62%) | Volatility: BB Upper |
| 2026 Target 2 | 54.34 (+2.23%) | Trend: SMA50 |
| 2026 Target 1 | 53.22 (+0.13%) | Trend: EMA9 |
| Current Price | 53.15 | Fortis Malar Hospitals's share price as of 15 Jun 2026 |
| Stop Loss 1 | 51.93 (-2.3%) | Volatility: BB Lower |
| Stop Loss 2 | 50.97 (-4.11%) | 71.80% Weekly Fib Retrace |
| Stop Loss 3 | 47.21 (-11.18%) | Volatility: ATR S1 |
Short-Term Technical Outlook
Current Technical Position: Fortis Malar Hospitals is showing mixed momentum signals near key moving averages.
Key Technical Level: The 50-day moving average at ₹54.34 serves as the nearest technical reference point.
Historical Returns: 3-month: +5.06% | 6-month: -13.79% | 1-year: -27.75%
Fortis Malar Hospitals Share Price Target For 2027
The line chart displays the monthly closing prices of Fortis Malar Hospitals with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fortis Malar Hospitals shares in 2027, see the table below.
Fortis Malar Hospitals Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 55.61 (+4.62%) | Volatility: BB Upper |
| 2027 Target 2 | 54.34 (+2.23%) | Trend: SMA50 |
| 2027 Target 1 | 53.22 (+0.13%) | Trend: EMA9 |
| Current Price | 53.15 | Fortis Malar Hospitals's share price as of 15 Jun 2026 |
| Stop Loss 1 | 51.93 (-2.3%) | Volatility: BB Lower |
| Stop Loss 2 | 50.97 (-4.11%) | 71.80% Weekly Fib Retrace |
| Stop Loss 3 | 47.21 (-11.18%) | Volatility: ATR S1 |
Long-Term Technical Outlook
52-Week Range Analysis: Fortis Malar Hospitals is currently trading at 34.2% of its 52-week range (₹40.75 - ₹77).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -27.75% | 3-year: +1.14% | 5-year: -21.88%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Fortis Malar Hospitals Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹53.15 | ||
| 2026 | ₹57.12 | +7.4694261523989% | ₹57.98 |
| 2027 | ₹57.64 | +0.91036414565827% | ₹58.50 |
| 2028 | ₹59.28 | +2.8452463566967% | ₹60.17 |
| 2029 | ₹64.41 | +8.6538461538461% | ₹65.38 |
| 2030 | ₹67.05 | +4.0987424312995% | ₹68.06 |
| 2031 | ₹73.86 | +10.156599552573% | ₹74.97 |
| 2032 | ₹77.56 | +5.0094773896561% | ₹78.72 |
| 2033 | ₹77.79 | +0.29654461062404% | ₹78.96 |
| 2034 | ₹79.22 | +1.8382825555984% | ₹80.41 |
| 2035 | ₹81.84 | +3.3072456450391% | ₹83.07 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Fortis Malar Hospitals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 97.81 Crore | Market valuation of Fortis Malar Hospitals's shares. |
| Revenue (TTM) | 58.85 Crore | Total revenue generated by Fortis Malar Hospitals over the past twelve months. |
| Net Income (TTM) | +45.32 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 92.28% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 85.09% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-100% | Change in revenue compared to the previous quarter. |
| Total Cash | 73.48 Lakh | Total amount of liquid funds available to Fortis Malar Hospitals. |
Is Fortis Malar Hospitals A Good Buy For Long Term?
Fortis Malar Hospitals, a small-cap stock with a market capitalization of ₹97.81 crore, shows mixed signals. While it boasts a high profit margin of 85.09% and a substantial net profit of ₹45.32 crore (TTM), its recent performance is concerning. Negative returns over the past 3, 6, and 12 months (-17.76%, -41.74%, -33.01% respectively) and a low cash balance of ₹73.48 lakh (Q1 2024-25) raise red flags. Considering the substantial negative returns, it's not a good buy for the long term at this time. Further investigation into the cause of the revenue drop (-100% QoQ) is crucial before considering investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
